The protective effect of ticagrelor on renal function in a mouse model of sepsis-induced acute kidney injury

Platelets

Volumn 30, Issue 2, 2019, Pages 199-205

  Li, Xiuhua ^a,b   Li, Yusheng ^a   Shen, Kan ^b   Li, Hongqiang ^a   Bai, Jianwen ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES   (China)

Author keywords

Acute kidney injury; apoptosis; platelet; sepsis; ticagrelor

Indexed keywords

CREATININE; INTERLEUKIN 1BETA; TICAGRELOR; ANTITHROMBOCYTIC AGENT;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; KIDNEY FUNCTION; KIDNEY TISSUE; MALE; MOUSE; MOUSE MODEL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; THROMBOCYTE; ANIMAL; COMPLICATION; DISEASE MODEL; HUMAN; PATHOLOGY; SEPSIS;

ACUTE KIDNEY INJURY; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; PLATELET AGGREGATION INHIBITORS; SEPSIS; TICAGRELOR;

EID: 85040999513     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537104.2017.1392499     Document Type: Article

References (26)

1. Uchino S., The epidemiology of acute renal failure in the world. Curr Opin Crit Care 2006;12:538–543.
2. Gomez H, Ince C, de Backer D, Pickkers P, Payen D, Hotchkiss J, Kellum JA. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014;41:3–11.
3. de Stoppelaar SF, van ‘t Veer C, van der Poll T. The role of platelets in sepsis. Thromb Haemost 2014;112:666–677.
4. Mederle K, Meurer M, Castrop H, Höcherl K. Inhibition of COX-1 attenuates the formation of thromboxane A2 and ameliorates the acute decrease in glomerular filtration rate in endotoxemic mice. Am J Physiol Renal Physiol 2015;309:F332–40.
5. Tőkés-Füzesi M, Woth G, Ernyey B, Vermes I, Mühl D, Bogár L, Kovács GL. Microparticles and acute renal dysfunction in septic patients. J Crit Care 2013;28:141–147.
6. Singbartl K, Forlow SB, Ley K. Platelet, but not endothelial P-selectin is critical for neutrophil-mediated acute postischemic renal failure. Faseb J 2001;15:2337–2344.
7. Li XH, Qian YB, Meng XX, Wang RL. Effect of platelet-derived p-selectin on neutrophil recruitment in a mouse model of sepsis-induced acute kidney injury. Chin Med J (Engl) 2017;130:1694–1699.
8. Cannon CP, Husted S, Harrington RA, Scirica BM, Emanuelsson H, Peters G, Storey RF. DISPERSE-2 Investigators. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. J Am Coll Cardiol 2007;50:1844–1851.
9. Husted S, Emanuelsson H, Heptinstall S, Sandset PM, Wickens M, Peters G. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin. Eur Heart J 2006;27:1038–1047.
10. Thomas MR, Storey RF. Effect of P2Y12 inhibitors on inflammation and immunity. Thromb Haemost 2015;114:490–497.
11. Gómez H, Kellum JA. Sepsis-induced acute kidney injury. Curr Opin Crit Care 2016;22:546–553.
12. Yaguchi A, Lobo FL, Vincent JL, Pradier O. Platelet function in sepsis. J Thromb Haemost 2004;2:2096–2102.
13. Schwarzenberger C, Sradnick J, Lerea KM, Goligorsky MS, Nieswandt B, Hugo CP, Hohenstein B. Platelets are relevant mediators of renal injury induced by primary endothelial lesions. Am J Physiol Renal Physiol 2015;308:F1238–46.
14. Storey RF, James SK, Siegbahn A, Varenhorst C, Held C, Ycas J, Husted SE, Cannon CP, Becker RC, Steg PG, et al. Lowe rmortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study. Platelets 2014;25:517–525.
15. Farid NA, Kurihara A, Wrighton SA. Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans. J Clin Pharmacol 2010;50:126–142.
16. Armstrong D, Summers C, Ewart L, Nylander S, Sidaway JE, van Giezen JJ. Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1. J Cardiovasc Pharmacol Ther 2014;19:209–219.
17. Rahman M, Gustafsson D, Wang Y, Thorlacius H, Braun OÖ. Ticagrelor reduces neutrophil recruitment and lung damage in abdominal sepsis. Platelets 2014;25:257–263.
18. Thomas MR, Outteridge SN, Ajjan RA, Phoenix F, Sangha GK, Faulkner RE, Ecob R, Judge HM, Khan H, West LE, et al. P2Y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model. Arterioscler Thromb Vasc Biol 2015;35:2562–2570.
19. Manne BK, Xiang SC, Rondina MT. Platelet secretion in inflammatory and infectious diseases. Platelets 2017;28:155–164.
20. Lee SY, Lee YS, Choi HM, Ko YS, Lee HY, Jo SK, Cho WY, Kim HK. Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med 2012;40:2997–3006.
21. Kosaka J, Lankadeva YR, May CN, Bellomo R. Histopathology of septic acute kidney injury: A systematic review of experimental data. Crit Care Med 2016;44:e897–903.
22. Jo SK, Cha DR, Cho WY, Kim HK, Chang KH, Yun SY, Won NH. Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells. Nephron 2002;91:406–415.
23. Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, Wittebole X, Dugernier T, Perrotin D, Tidswell M, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. Jama 2013;309:1154–1162.
24. Zarjou A, Agarwal A. Sepsis and acute kidney injury. J Am Soc Nephrol 2011;22:999–1006.
25. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW, 3rd, Bland KI, Chaudry IH. Cecal ligation and puncture. Shock 2005;24(Suppl 1):52–57.
26. Zhou F, Peng ZY, Bishop JV, Cove ME, Singbartl K, Kellum JA. Effects of fluid resuscitation with 0.9% saline versus a balanced electrolyte solution on acute kidney injury in a rat model of sepsis. Crit Care Med 2014;42:e270–e278.